Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria
- 19 February 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (6), 926-931
- https://doi.org/10.1016/j.jcf.2021.02.001
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K23HL136934)
- Cystic Fibrosis Foundation (CAVERL17A0)
This publication has 30 references indexed in Scilit:
- Antianaerobic Antimicrobials: Spectrum and Susceptibility TestingClinical Microbiology Reviews, 2013
- Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary ExacerbationAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Cystic Fibrosis Pulmonary GuidelinesAmerican Journal of Respiratory and Critical Care Medicine, 2009
- A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patientsProceedings of the National Academy of Sciences of the United States of America, 2008
- Evidence-Based Practice Recommendations for Nutrition-Related Management of Children and Adults with Cystic Fibrosis and Pancreatic Insufficiency: Results of a Systematic ReviewJournal of the American Dietetic Association, 2008
- Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesisThorax, 2007
- Comparative In Vitro Susceptibilities of 396 Unusual Anaerobic Strains to Tigecycline and Eight Other Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 2006
- Defining a pulmonary exacerbation in cystic fibrosisThe Journal of Pediatrics, 2001
- Susceptibility of Anaerobic Bacteria to 23 Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 1976